CERS Collar Strategy
CERS (Cerus Corporation), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.
CERS (Cerus Corporation) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $521.0M, a beta of 1.63 versus the broader market, a 52-week range of 1.15-3.15, average daily share volume of 2.1M, a public-listing history dating back to 1997, approximately 614 full-time employees. These structural characteristics shape how CERS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.63 indicates CERS has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a collar on CERS?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
Current CERS snapshot
As of May 15, 2026, spot at $2.37, ATM IV 108.70%, IV rank 18.47%, expected move 31.16%. The collar on CERS below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this collar structure on CERS specifically: IV regime affects collar pricing on both sides; compressed CERS IV at 108.70% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 31.16% (roughly $0.74 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CERS expiries trade a higher absolute premium for lower per-day decay. Position sizing on CERS should anchor to the underlying notional of $2.37 per share and to the trader's directional view on CERS stock.
CERS collar setup
The CERS collar below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CERS near $2.37, the first option leg uses a $2.49 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CERS chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CERS shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $2.37 | long |
| Sell 1 | Call | $2.49 | N/A |
| Buy 1 | Put | $2.25 | N/A |
CERS collar risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
CERS collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on CERS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use collar on CERS
Collars on CERS hedge an existing long CERS stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
CERS thesis for this collar
The market-implied 1-standard-deviation range for CERS extends from approximately $1.63 on the downside to $3.11 on the upside. A CERS collar hedges an existing long CERS position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current CERS IV rank near 18.47% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CERS at 108.70%. As a Healthcare name, CERS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CERS-specific events.
CERS collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CERS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CERS alongside the broader basket even when CERS-specific fundamentals are unchanged. Always rebuild the position from current CERS chain quotes before placing a trade.
Frequently asked questions
- What is a collar on CERS?
- A collar on CERS is the collar strategy applied to CERS (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With CERS stock trading near $2.37, the strikes shown on this page are snapped to the nearest listed CERS chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are CERS collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the CERS collar priced from the end-of-day chain at a 30-day expiry (ATM IV 108.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CERS collar?
- The breakeven for the CERS collar priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CERS market-implied 1-standard-deviation expected move is approximately 31.16%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on CERS?
- Collars on CERS hedge an existing long CERS stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current CERS implied volatility affect this collar?
- CERS ATM IV is at 108.70% with IV rank near 18.47%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.